Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
10.2%
% of FHLC's 349 holdings also in HRTS
82.5%
% of HRTS's 41 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 10.9% | 10.9% |
|
UNITEDHEALTH GROUP INC | 7.3% | 5.6% | 5.6% |
|
ABBOTT LABORATORIES | 3.8% | 4.0% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% | 2.8% | 2.8% |
|
MERCK & CO. INC. | 3.8% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to HRTS
|
JOHNSON & JOHNSON | 6.4% |
|
ABBVIE INC | 4.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
PFIZER INC | 2.4% |
|
STRYKER CORP | 2.1% |
|
UNITEDHEALTH GROUP INC | 1.7% |
|
ELEVANCE HEALTH INC | 1.5% |
|
CIGNA CORPORATION | 1.4% |
|
MERCK & CO. INC. | 1.4% |
|
CVS CAREMARK CORP | 1.3% |
FHLC Underweight Relative to HRTS
|
BRIDGEBIO PHARMA, INC. | -4.2% |
 |
ASTRAZENECA PLC | -4.0% |
 |
NOVO NORDISK A/S-B | -3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
NOVARTIS AG | -3.1% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.3% |
|
CYTOKINETICS INC | -2.2% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
VERTEX PHARMACEUTICALS INC | -1.6% |